Klaria Pharma Holding AB develops pharmaceutical products using an alginate-based oral film for transmucosal drug delivery, including programs for migraine, acute allergic reactions, and transplant rejection.

Social media

Klaria Pharma Holding Logo

Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.

About Klaria Pharma Holding

Klaria Pharma Holding AB is a Swedish pharmaceutical company developing drug products using an alginate-based film that adheres to the oral mucosa and delivers active substances directly into the bloodstream. Its development programs include a sumatriptan film for migraine, an epinephrine/adrenaline film for acute allergic reactions, and a sirolimus film intended to help prevent organ-transplant rejection. The company focuses on treatments where its transmucosal delivery technology may provide an alternative to injections or other existing administration methods.

Address

Virdings AllE 2
Uppsala, 754 50
Sweden

Year founded

2014

Number of employees

0-100

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Add Klaria logo and brand data to your app or website

Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.

<img src="https://img.logokit.com/klaria.com" />

Report inaccurate data

Request an update to help us keep the brand up-to-date.

One API,
Millions of Logos

Get Started Contact Us
One API, Millions of Logos